Medical and Dental Consultantsĺ Association of Nigeria
Home - About us - Editorial board - Search - Ahead of print - Current issue - Archives - Submit article - Instructions - Subscribe - Advertise - Contacts - Login 
  Users Online: 330   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
 

    Article Cited by others

ORIGINAL ARTICLE

Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study

Yazici O, Gulen S T, Yenisey C, Eryilmaz U, Abas B I, Polatli M

Year : 2020| Volume: 23| Issue : 6 | Page no: 817-824

   This article has been cited by
 
1 PRKCD as a potential therapeutic target for chronic obstructive pulmonary disease
Siqi Li, Qiong Huang, Dongbo Zhou, Baimei He
International Immunopharmacology. 2022; 113: 109374
[Pubmed]  [Google Scholar] [DOI]
2 Effect of physical training on cytokine expression in CD4+ T lymphocytes in subjects with stable COPD
Juliana S. Uzeloto, Alessandra C. de Toledo-Arruda, Bruna S.A. Silva, Aline M.M. Braz, Fabiano F. de Lima, Isis Grigoletto, Dionei Ramos, Marjorie A. Golim, Ercy M.C. Ramos
Therapeutic Advances in Respiratory Disease. 2022; 16: 1753466622
[Pubmed]  [Google Scholar] [DOI]
3 Markers of Immune Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Combination with Chronic Obstructive Pulmonary Disease
I. O. Khramtsova, M. A. Derbak
Ukra´ns'kij ×urnal medicini, býologý´ ta sportu. 2021; 6(4): 119
[Pubmed]  [Google Scholar] [DOI]
4 Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer
Jian Chen, Xincai Li, ChaoLin Huang, Ying Lin, Qingfu Dai
Technology in Cancer Research & Treatment. 2020; 19: 1533033820
[Pubmed]  [Google Scholar] [DOI]

 

Read this article